Suppr超能文献

假定的σ受体激动剂N-烯丙基去甲左啡诺和环佐辛的立体异构体在恒河猴中的增强特性

Reinforcing properties of stereoisomers of the putative sigma agonists N-allylnormetazocine and cyclazocine in rhesus monkeys.

作者信息

Slifer B L, Balster R L

出版信息

J Pharmacol Exp Ther. 1983 Jun;225(3):522-8.

PMID:6306209
Abstract

There are many similarities in the effects of phencyclidine (PCP) and opioids with sigma agonist activity such as N-allylnormetazocine (SKF-10,047) and cyclazocine. Yet PCP and sigma agonists differ in reinforcing properties. PCP is reliably self-administered in animal models and has abuse liability in humans, whereas (+/-)-N-allylnormetazocine and (+/-)-cyclazocine are not self-administered or abused. Inasmuch as other research has demonstrated differences in the selectivity of PCP-like effects of the stereoisomers of opioids, this study compared the reinforcing properties of PCP to the reinforcing properties of isomers of N-allylnormetazocine and cyclazocine. Rhesus monkeys were trained to lever-press on a fixed-ratio 10 schedule for i.v. cocaine (50 micrograms/kg/injection). During substitution tests, cocaine was replaced with various doses of test drugs or vehicle. The drugs tested were PCP, (+/-)-N-allylnormetazocine, (-)-N-allylnormetazocine, (+)-N-allylnormetazocine, (+/-)-cyclazocine, (-)-cyclazocine and (+)-cyclazocine. PCP and the (+)-isomers of both benzomorphans, at one or more doses, were self-administered at rates which exceeded rates maintained by vehicle and which equaled or exceeded cocaine-maintained base-line rates. Neither the racemates nor the (-)-isomers of N-allylnormetazocine or cyclazocine were self-administered by the monkeys at rates which were greater than vehicle control levels of responding. Reinforcing doses of the three compounds resulted in injections evenly distributed across the 60-min session in a pattern similar to cocaine self-administration, whereas the racemic mixtures and the (-)-isomers produced negatively accelerated patterns of injections which resembled typical saline patterns of extinction responding. These data provide further evidence that the (+)-isomers of sigma agonists are more selective for PCP-like effects than the (-)-isomers in monkeys.

摘要

苯环利定(PCP)与具有西格玛激动剂活性的阿片类药物(如N -烯丙基去甲左啡诺(SKF - 10,047)和环唑辛)的作用有许多相似之处。然而,PCP和西格玛激动剂在强化特性方面存在差异。在动物模型中,PCP能可靠地自我给药,且在人类中有滥用倾向,而(±)-N -烯丙基去甲左啡诺和(±)-环唑辛则不会自我给药或被滥用。鉴于其他研究已证明阿片类药物立体异构体的PCP样效应的选择性存在差异,本研究比较了PCP与N -烯丙基去甲左啡诺和环唑辛异构体的强化特性。恒河猴经过训练,按照固定比例10的程序静脉注射可卡因(50微克/千克/注射)。在替代试验中,可卡因被不同剂量的受试药物或赋形剂取代。受试药物包括PCP、(±)-N -烯丙基去甲左啡诺、(-)-N -烯丙基去甲左啡诺、(+)-N -烯丙基去甲左啡诺、(±)-环唑辛、(-)-环唑辛和(+)-环唑辛。PCP以及两种苯吗喃类药物的(+)-异构体,在一个或多个剂量下,自我给药的速率超过了赋形剂维持的速率,且等于或超过了可卡因维持的基线速率。N -烯丙基去甲左啡诺或环唑辛的外消旋体和(-)-异构体都未被猴子以高于赋形剂对照反应水平的速率自我给药。三种化合物的强化剂量导致注射在60分钟的试验期间均匀分布,其模式类似于可卡因自我给药,而外消旋混合物和(-)-异构体产生负加速的注射模式,类似于典型的生理盐水消退反应模式。这些数据进一步证明,在猴子中,西格玛激动剂的(+)-异构体对PCP样效应的选择性高于(-)-异构体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验